Ramon Gomez De La Cuesta

Title: Ramon Gomez De La Cuesta: Innovator in Antibody Technology

Introduction

Ramon Gomez De La Cuesta is a notable inventor based in Hertfordshire, GB. He has made significant contributions to the field of biotechnology, particularly in the development of modified antibodies for therapeutic applications. With a total of 2 patents, his work is paving the way for advancements in drug conjugation.

Latest Patents

Ramon's latest patents focus on CL and/or CH1 mutated antibodies for drug conjugation. These antibodies have modified constant regions that allow for the conjugation of the antibody to a payload, such as a therapeutic agent. The preferred antibodies include a mutation at light chain position 180, with the most favorable mutations being to residues selected from C, K, Q, or a non-natural amino acid. Additionally, other mutations may be combined with the mutation at position 180, including various positions on both the light and heavy chains according to a positional numbering convention.

Career Highlights

Ramon is currently employed at Lonza Inc., where he continues to innovate in the field of antibody technology. His work is instrumental in enhancing the efficacy of therapeutic agents through advanced antibody modifications.

Collaborations

Ramon collaborates with esteemed colleagues, including Jesús Zurdo and Lars Arne Andreas Arnell. Their combined expertise contributes to the success of their projects and the advancement of their research.

Conclusion

Ramon Gomez De La Cuesta is a prominent figure in the biotechnology sector, with a focus on antibody technology that holds promise for future therapeutic applications. His innovative work and collaborations are set to make a lasting impact in the field.